Elsevier Launches New Online Oncology Journal
London, May 31, 2006 – Elsevier, a world-leading healthcare and scientific publisher, is set to launch a new online-only oncology review journal. Update on Cancer Therapeutics, edited by Giuseppe Giaccone, Richard Schilsky and Paul Sondel, will be published quarterly, premiering in June 2006. Update on Cancer Therapeutics will provide a valuable new resource for clinicians seeking to stay current by publishing timely reviews on progress and achievements in clinical oncology and cancer therapeutics. Reviews focus on recent advances in the understanding of anti-cancer drugs, biological agents and the multi-disciplinary management of specific malignancies.
"We are committed to providing up-to-date, useful and clear reviews of the most important perspectives in oncology that have been recently identified," explained Editor, Paul Sondel. “Each issue of Update on Cancer Therapeutics reflects a spectrum of reviews presenting recent data, conclusions and recommendations that advance our understanding of anti-cancer drugs, specific malignancies and immunotherapy-host responses,” added Editor Richard Schilsky. "This format also enables user-friendly focused summaries of newer concepts and practices that complement both standard textbook chapters as well as initial reports of new findings," noted Editor Giuseppe Giaccone.
Subscribers will have full access to each issue as well as articles in press on the journal’s website, www.updateoncancer.com. Update on Cancer Therapeutics will also be accessible through Elsevier’s online database, ScienceDirect, the world's largest electronic collection of science, technology and medicine full text and bibliographic information.
# # #
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com
Name Chelsea Drake
Phone +44 (0) 207 424 4276